United States· US:0378-5246_24da4379-1283-4c66-97bd-643b27a15368
Almotriptan Malate
A medicinal product containing almotriptan malate, registered in United States by Mylan Pharmaceuticals Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ALMOTRIPTAN MALATE
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1103785246852 BLISTER PACK in 1 CARTON (0378-5246-85) / 6 TABLET, FILM COATED in 1 BLISTER PACK (0378-5246-32)
- ndc110378-5246-85
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Almotriptan malate in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Denmark · Almogran
- France · Almotriptan Arrow, Almotriptan Eg
- United Kingdom (Northern Ireland) · Almotriptan Zentiva
- Iceland · Almogran
- Italy · Almotriptan Zentiva
- Lithuania · Almotriptan Zentiva
- Latvia · Almotriptan Zentiva
- Poland · Almozen, Dezamigren
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/617d2a1a-18a3-4857-b118-ed64b8e263d9 GET /v1/drugs/617d2a1a-18a3-4857-b118-ed64b8e263d9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "12.5",
"substance": "ALMOTRIPTAN MALATE",
"productndc": "0378-5246",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA205171",
"marketing_category": "ANDA"
}See everything about almotriptan malate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.